Abstract
This review presents the main advances in the design of antitumor platinum complexes over the last five years. Particular attention is paid to unconventional antitumor platinum compounds (complexes in the trans configuration, Pt(IV) complexes with S and P donor ligands, multinuclear complexes).
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have